Integrating splice-isoform expression into genome-scale models characterizes breast cancer metabolism

Bioinformatics

Volumn 34, Issue 3, 2018, Pages 494-501

  Angione, Claudio ^a  

^a TEESSIDE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN;

ALTERNATIVE RNA SPLICING; BREAST TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PROCEDURES; RNA SPLICING; SOFTWARE;

ALTERNATIVE SPLICING; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN ISOFORMS; RNA SPLICING; SOFTWARE;

EID: 85041416386     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btx562     Document Type: Article

References (55)

1. Angione, C. et al. (2016) Multiplex methods provide effective integration of multi-omic data in genome-scale models. BMC Bioinformatics, 17, 257.
2. Angione, C. et al. (2015a) Predictive analytics of environmental adaptability in multi-omic network models. Sci. Rep., 5, 15147.
3. Angione, C. et al. (2015b) A hybrid of metabolic flux analysis and Bayesian factor modeling for multi-omics temporal pathway activation. ACS Synth. Biol., 4, 880-889.
4. Becker, S.A. et al. (2008) Context-specific metabolic networks are consistent with experiments. PLoS Comput. Biol., 4, e1000082.
5. Belkaid, A. et al. (2006) Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin. FEBS Lett., 580, 3746-3752.
6. Cadenas, C. et al. (2012) Glycerophospholipid profile in oncogene-induced senescence. Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids, 1821, 1256-1268.
7. Conway, M. et al. (2016) Iterative multi level calibration of metabolic networks. Curr. Bioinf., 11, 93-105.
8. Costanza, J. et al. (2012) Robust design of microbial strains. Bioinformatics, 28, 3097-3104.
9. Dai, D. et al. (2016) Pretreatment tg/hdl-c ratio is superior to triacylglycerol level as an independent prognostic factor for the survival of triple negative breast cancer patients. J. Cancer, 7, 1747.
10. Doldo, E. et al. (2015) Vitamin a, cancer treatment and prevention: the new role of cellular retinol binding proteins. BioMed Res. Int., 2015, 1.
11. Duarte, N.C. et al. (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. USA, 104, 1777-1782.
12. Elliott, R. et al. (2012) Mitochondria organelle transplantation: introduction of normal epithelial mitochondria into human cancer cells inhibits proliferation and increases drug sensitivity. Breast Cancer Res. Treat., 136, 347-354.
13. Feng, Y.H. et al. (2016) Elovl6 is a poor prognostic predictor in breast cancer. Oncol. Lett., 12, 207-212.
14. Geng, J. et al. (2017) In silico analysis of human metabolism-reconstruction, contextualization and application of genome-scale models. Curr. Opin. Syst. Biol., 2, 28-37.
15. Ghaffari, P. et al. (2015) Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling. Sci. Rep., 5, Article number 8183.
16. Gonzalez, M.J. et al. (2012) The bio-energetic theory of carcinogenesis. Med. Hypotheses, 79, 433-439.
17. Harrow, J. et al. (2012) Gencode: the reference human genome annotation for the encode project. Genome Res., 22, 1760-1774.
18. Hart, T. et al. (2013) Finding the active genes in deep rna-seq gene expression studies. BMC Genomics, 14, 778.
19. Jerby, L. et al. (2012) Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res., 72, 5712-5720.
20. Jovanovic, M. et al. (2015) Dynamic profiling of the protein life cycle in response to pathogens. Science, 347, 1259038.
21. Kacser, H. et al. (1995) The control of flux. Biochem. Soc. Trans., 23, 341-366.
22. Kent, E. et al. (2013) What can we learn from global sensitivity analysis of biochemical systems? PLoS One, 8, e79244.
23. Kosti, I. et al. (2016) Cross-tissue analysis of gene and protein expression in normal and cancer tissues. Sci. Rep., 6, Article number 24799.
24. Langmead, B. et al. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, R25.
25. Li, B. et al. (2011) RSEM: accurate transcript quantification from rna-seq data with or without a reference genome. BMC Bioinformatics, 12, 323.
26. Li, J. et al. (2010) A genome-wide association scan on estrogen receptor-negative breast cancer. Breast Cancer Res., 12, R93.
27. Li, J. et al. (2016) Cancer RNA-Seq Nexus: a database of phenotype-specific transcriptome profiling in cancer cells. Nucleic Acids Res., 44, D944-D951.
28. Li, J.J. et al. (2014) System wide analyses have underestimated protein abundances and the importance of transcription in mammals. PeerJ, 2, e270.
29. Locasale, J.W. et al. (2011) Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet., 43, 869-874.
30. Machado, D. et al. (2014) Systematic evaluation of methods for integration of transcriptomic data into constraint-based models of metabolism. PLoS Comput. Biol., 10, e1003580.
31. Markert, E.K. et al. (2015) Mathematical models of cancer metabolism. Cancer Metab., 3, 1-13.
32. Mi, H. et al. (2016) Panther version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res., 44, D336-D342.
33. Nagarajan, A. et al. (2016) Oncogene-directed alterations in cancer cell metabolism. Trends Cancer, 2, 365-377.
34. Ohashi, Y. et al. (2004) Ubiquinol cytochrome c reductase (uqcrfs1) gene amplification in primary breast cancer core biopsy samples. Gynecol. Oncol., 93, 54-58.
35. Pan, Q. et al. (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet., 40, 1413-1415.
36. Pecqueur, C. et al. (2013) Targeting metabolism to induce cell death in cancer cells and cancer stem cells. Int. J. Cell Biol., 2013, 1.
37. Pfau, T. et al. (2016) Towards improved genome-scale metabolic network reconstructions: unification, transcript specificity and beyond. Brief. Bioinf., 17, 1060-1069.
38. Qi, Z. et al. (2017) Inference of cancer mechanisms through computational systems analysis. Mol. BioSyst., 13, 489-497.
39. Richardson, A.D. et al. (2008) Central carbon metabolism in the progression of mammary carcinoma. Breast Cancer Res. Treat., 110, 297-307.
40. Roberts, A. et al. (2013) Streaming fragment assignment for real-time analysis of sequencing experiments. Nat. Methods, 10, 71-73.
41. Ryu, J.Y. et al. (2015) Reconstruction of genome-scale human metabolic models using omics data. Integrative Biol., 7, 859-868.
42. Santidrian, A.F. et al. (2013) Mitochondrial complex i activity and nad?/nadh balance regulate breast cancer progression. J. Clin. Investig., 123, 1068.
43. Schellenberger, J. et al. (2011) Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat. Protoc., 6, 1290-1307.
44. Schramm, G. et al. (2010) Analyzing the regulation of metabolic pathways in human breast cancer. BMC Med. Genomics, 3, 39.
45. Sidi, Y. et al. (1988) Growth inhibition and induction of phenotypic alterations in mcf-7 breast cancer cells by an imp dehydrogenase inhibitor. Br. J. Cancer, 58, 61.
46. Sigoillot, F.D. et al. (2004) Breakdown of the regulatory control of pyrimidine biosynthesis in human breast cancer cells. Int. J. Cancer, 109, 491-498.
47. Smedley, D. et al. (2015) The biomart community portal: an innovative alternative to large, centralized data repositories. Nucleic Acids Res., 43, W589-W598.
48. Stephens, Z.D. et al. (2015) Big data: astronomical or genomical? PLoS Biol., 13, e1002195.
49. Sukocheva, O. et al. (2014) Role of sphingolipids in oestrogen signalling in breast cancer cells: an update. J. Endocrinol., 220, R25-R35.
50. Tusher, V.G. et al. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA, 98, 5116-5121.
51. Vijayakumar, S. et al. (2017) Seeing the wood for the trees: a forest of methods for optimization and omic-network integration in metabolic modelling. Brief. Bioinf., bbx053.
52. Warburg, O. et al. (1927) The metabolism of tumors in the body. J. Gen. Physiol., 8, 519-530.
53. Wong, N. et al. (2015) Pkm2 contributes to cancer metabolism. Cancer Lett., 356, 184-191.
54. Yang, L. et al. (2017) Glutaminolysis: a hallmark of cancer metabolism. Annual Review of Biomed. Eng., 19, 163-194.
55. Yizhak, K. et al. (2015) Modeling cancer metabolism on a genome scale. Mol. Syst. Biol., 11, 817.